The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-10B MM: Novel therapeutic approaches

Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Masuzu Ueda (Division of Hematology, Depaertment of Internal Medicine, Jichi Medical University, Japan)

[OS3-10B-4] Combination of venetoclax and Mcl-1 inhibitor shows an excellent cytotoxic activity against myeloma

Akira Yoshida1, Takuya Ogawa2, Hideki Yagi2 (1.Dept of Hematology, International University of Health and Welfare, 2.Dept of Pharmacy, International University of Health and Welfare, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password